Graphene Frontier, spun off from the University of Pennsylvania, is producing graphene using their own Atmospheric Pressure CVD (APCVD) technology, a roll-to-roll process that does not require a vacuum. We now hear that the company raised $1.6 million in Series Seed B funding.
The round was led by Trimaran Capital Partners with participation from R2M Investments and return backers WEMBA 36 Angels. Graphene Frontiers will use the money to hire additional researchers, expand the lab facilities and accelerate the development of their proprietary GFET sensors and manufacturing process.
Graphene Frontiers also launched the "six sensors" brand for highly-sensitive chemical and biological GFET-based sensors. These are especially promising to diagnose diseases with multiple markers such as cancers and illnesses currently diagnosed using ELISA technologies.
In November 2013 I posted an article describing Graphene Frontier's technology and business following my talk with Michael D. Patterson, the company's CEO.